搜索
Nutriband Inc
NTRB添加自选
3.110USD
-0.010-0.34%
收盘 08-07 16:00（美东）报价延迟15分钟
37.81M总市值
亏损市盈率 TTM
关于 Nutriband Inc 公司
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
Nutriband Inc 简介
公司代码NTRB
公司名称Nutriband Inc
上市日期Jun 20, 2017
CEOMelnik (Serguei)
员工数量- -
证券类型Ordinary Share
年结日Jun 20
公司地址121 S Orange Ave Ste 1500
城市ORLANDO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编32801-3241
电话14073776695
网址https://nutriband.com/
公司代码NTRB
上市日期Jun 20, 2017
CEOMelnik (Serguei)
Nutriband Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Serguei Melnik
Mr. Serguei Melnik
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
839.00K
-11.97%
Mr. Gerald Goodman
Mr. Gerald Goodman
Chief Financial Officer
Chief Financial Officer
86.33K
--
Dr. Jeff Patrick, Pharm.D.
Dr. Jeff Patrick, Pharm.D.
Chief Scientific Officer
Chief Scientific Officer
36.61K
--
Mr. Radu Bujoreanu
Mr. Radu Bujoreanu
Independent Director
Independent Director
15.75K
--
Mr. Mark Hamilton
Mr. Mark Hamilton
Independent Director
Independent Director
13.96K
--
Ms. Irina Gram
Ms. Irina Gram
Independent Director
Independent Director
1.17K
--
Dr. Alan Smith, Ph.D.
Dr. Alan Smith, Ph.D.
Chief Operating Officer, President of 4P Therapeutics
Chief Operating Officer, President of 4P Therapeutics
--
--
Prof. Dr. Stefani C. Mancas
Prof. Dr. Stefani C. Mancas
Independent Director
Independent Director
--
--
Mr. Sergei Glinka
Mr. Sergei Glinka
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Serguei Melnik
Mr. Serguei Melnik
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
Chairman of the Board, President, Interim Chief Executive Officer, Secretary
839.00K
-11.97%
Mr. Gerald Goodman
Mr. Gerald Goodman
Chief Financial Officer
Chief Financial Officer
86.33K
--
Dr. Jeff Patrick, Pharm.D.
Dr. Jeff Patrick, Pharm.D.
Chief Scientific Officer
Chief Scientific Officer
36.61K
--
Mr. Radu Bujoreanu
Mr. Radu Bujoreanu
Independent Director
Independent Director
15.75K
--
Mr. Mark Hamilton
Mr. Mark Hamilton
Independent Director
Independent Director
13.96K
--
Ms. Irina Gram
Ms. Irina Gram
Independent Director
Independent Director
1.17K
--
常见问题
Nutriband Inc的前五大股东是谁？
Nutriband Inc 的前五大股东如下：Mr. Serguei Melnik
有多少机构持有Nutriband Inc(NTRB)的股份？
截至2026Q1，共有45家机构持有Nutriband Inc的股份，合计持有的股份价值约为579.57K，占公司总股份的4.77%。与2025Q4相比，机构持股有所增加，增幅为106153.00。